Cargando…

Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa

OBJECTIVES: HIV-infected patients are at increased risk for cardiovascular disease (CVD). However, general population CVD risk prediction equations that identify HIV-infected patients at elevated risk have not been widely assessed in sub-Saharan African (SSA). METHODS: HIV-infected adults from 30–50...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosepele, Mosepele, Hemphill, Linda C., Palai, Tommy, Nkele, Isaac, Bennett, Kara, Lockman, Shahin, Triant, Virginia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325544/ https://www.ncbi.nlm.nih.gov/pubmed/28235058 http://dx.doi.org/10.1371/journal.pone.0172897

Ejemplares similares

The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for cholesterol management and for cardiovascular risk stratification: A reappraisal
por: Bansal, Manish, et al.
Publicado: (2014)

Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls
por: Mosepele, Mosepele, et al.
Publicado: (2017)

HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long–term antiretroviral therapy in Botswana
por: Mosepele, Mosepele, et al.
Publicado: (2018)

External validation of the ACC/AHA ASCVD risk score in a Colombian population cohort
por: Rodríguez-Ariza, Carlos Daniel, et al.
Publicado: (2023)

Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected Individuals
por: Mosepele, Mosepele, et al.
Publicado: (2018)

The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review
por: Hyle, Emily P., et al.
Publicado: (2017)

Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline
por: Dorans, Kirsten S., et al.
Publicado: (2018)

Comparison of Framingham Risk Scores (FRS), Joint British Society (JBS3), and American College of Cardiology/American Heart Association (ACC/AHA) Cardiovascular Risk Scores Among Adults With First Myocardial Infarction
por: Raj, Madhu P, et al.
Publicado: (2023)

Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)

The 2020 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Management of Patients with Valvular Heart Disease. Should the World Jump In?
por: Gomes, Walter J, et al.
Publicado: (2021)

Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)
por: Parums, Dinah V.
Publicado: (2021)

Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
por: Wong, Nathan D., et al.
Publicado: (2022)

American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
por: Qureshi, Waqas T., et al.
Publicado: (2017)

Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management
por: AlAhmad, Mohammad M., et al.
Publicado: (2023)

Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore
por: Setia, Sajita, et al.
Publicado: (2015)

Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers
por: Akhabue, Ehimare, et al.
Publicado: (2017)

Representation of cardiovascular magnetic resonance in the AHA / ACC guidelines
por: von Knobelsdorff-Brenkenhoff, Florian, et al.
Publicado: (2017)

2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards
por: Bozkurt, Biykem, et al.
Publicado: (2022)

Comparison of the ACC/AHA and Framingham algorithms to assess cardiovascular risk in HIV-infected patients
por: Pinto Neto, Lauro Ferreira da Silva, et al.
Publicado: (2017)

Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors
por: Dansinger, Michael L., et al.
Publicado: (2019)

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline
por: Cardoso, Rhanderson, et al.
Publicado: (2022)

Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
por: Vallejo-Vaz, Antonio J., et al.
Publicado: (2022)

The South American Society of Cardiology (SSC) and the Latin American Association of Cardiac and Endovascular Surgery (LACES) Statement on the 2021 ACC/AHA/SCAI Guidelines for Coronary Artery Revascularization
por: Soca, Gerardo, et al.
Publicado: (2023)

Assessment of 2013 AHA/ACC ASCVD risk scores with behavioral characteristics of an urban cohort in India: Preliminary analysis of Noncommunicable disease Initiatives and Research at AMrita (NIRAM) study
por: Menon, Vidya P., et al.
Publicado: (2016)

L-Arginine, Nitric Oxide, and Endothelial Dysfunction Underlying Atherosclerotic Cardiovascular Disease (ASCVD)
por: Shimabukuro, Michio
Publicado: (2023)

Presentation and mortality of patients hospitalised with acute heart failure in Botswana
por: Mwita, Julius Chacha, et al.
Publicado: (2017)

Statin Utilization Among Human-Immunodeficiency Virus (HIV)-Infected Individuals Based on the 2013 American College of Cardiology and American Heart Association (ACC/AHA) Blood Cholesterol Guideline
por: Non, Lemuel, et al.
Publicado: (2017)

Application of the American College of Cardiology (ACC/AHA) 2017 Guideline for the Management of Hypertension in Adults and Comparison with the 2014 Eighth Joint National Committee Guideline
por: AlAhmad, Mohammad, et al.
Publicado: (2021)

2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
por: Gerhard-Herman, Marie D., et al.
Publicado: (2016)

Female‐friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
por: Wenger, Nanette K.
Publicado: (2019)

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
por: Jensen, Michael D., et al.
Publicado: (2013)

Hypertension Defined by 2017 ACC/AHA Guideline, Ideal Cardiovascular Health Metrics, and Risk of Cardiovascular Disease: A Nationwide Prospective Cohort Study
por: Wu, Shujing, et al.
Publicado: (2022)

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
por: Okerson, Ted, et al.
Publicado: (2017)

Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan
por: Olufade, Temitope, et al.
Publicado: (2017)

Blood Pressure Change from Normal to 2017 ACC/AHA Defined Stage 1 Hypertension and Cardiovascular Risk
por: Son, Joung Sik, et al.
Publicado: (2019)

Preventing Atherosclerotic Cardiovascular Disease Using American College of Cardiology and American Heart Association Prevention Guidelines: Some Good News, But Caveats Remain
por: Stone, Neil J.
Publicado: (2016)

2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
por: Gerhard-Herman, Marie D., et al.
Publicado: (2016)

Functional Impairment of Endothelial Colony Forming Cells (ECFC) in Patients with Severe Atherosclerotic Cardiovascular Disease (ASCVD)
por: Simoncini, Stéphanie, et al.
Publicado: (2022)

Subclinical Hypertension-Mediated Organ Damage (HMOD) in Hypertension: Atherosclerotic Cardiovascular Disease (ASCVD) and Calcium Score
por: Rizzoni, Damiano, et al.
Publicado: (2022)

Society for Cardiovascular Magnetic Resonance perspective on the 2021 AHA/ACC Chest Pain Guidelines
por: Arai, Andrew E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_alm13cku9a9n1l0v3pn7af5rtn